Tremamunno, Giuseppe
Varga-Szemes, Akos https://orcid.org/0000-0002-2781-7462
Kravchenko, Dmitrij
Laghi, Andrea
Bamberg, Fabian
Halfmann, Moritz C.
Suranyi, Pál Spruill
Vecsey-Nagy, Milán
Emrich, Tilman
Hagar, Muhammad Taha
Funding for this research was provided by:
Siemens Healthineers (Unrestricted Research Grant)
Article History
Received: 20 November 2024
Revised: 20 March 2025
Accepted: 31 March 2025
First Online: 1 May 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Akos Varga-Szemes.
: The authors of this manuscript declare relationships with the following companies: A.V.-S.: Unrestricted research grant, speakers’ bureau (Siemens Healthineers); Consultant, shareholder (Elucid Bioimaging). T.E.: Unrestricted research grant, speakers’ bureau (Siemens Healthineers); Consultant (Circle Cardiovascular Imaging). F.B.: Unrestricted research grant, speakers’ bureau (Siemens Healthineers, Bayer Healthcare). M.T.H.: Speakers’ bureau (Siemens Healthineers). All other authors: No conflicts of interest. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: One of the authors has significant statistical expertise.
: Written informed consent was obtained from all patients in this study.
: Institutional Review Board approval was obtained.
: Some study subjects or cohorts have been previously reported in Aquino et al (2023) . However, this study investigates a different scope, leveraging iodine-specific PCD-CT imaging for myocardial late enhancement assessment.
: